Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-11-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.167.10.5583PMID 11698429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer vaccines

  2005cited by this paper
• Myosin V and iNOS expression is enhanced in J774 murine macrophages treated with IFN-gamma.

  2001cited by this paper
• IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line

  2001cited by this paper
• Comparison of tumor necrosis factor-α effect on the expression of iNOS in macrophage and cardiac myocytes

  2001cited by this paper
• The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass

  2001cited by this paper
• Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1.

  2001cited by this paper
• STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts.

  2001cited by this paper
• Identification of protein kinase C isoforms involved in interferon-gamma-induced expression of inducible nitric oxide synthase in murine BV2 microglia.

  2001cited by this paper
• IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line.

  2001cited by this paper
• Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.

  2000cited by this paper
• Activated Macrophages Direct Apoptosis and Suppress Mitosis of Mesangial Cells1

  2000cited by this paper
• Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing

  2000cited by this paper
• Angiogenesis and cancer metastasis.

  2000cited by this paper
• Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo1

  2000cited by this paper
• Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

  2000cited by this paper
• Interferon γ Eliminates Responding Cd4 T Cells during Mycobacterial Infection by Inducing Apoptosis of Activated Cd4 T Cells

  2000cited by this paper
• Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms

  2000cited by this paper
• Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors.

  2000cited by this paper
• Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).

  1999cited by this paper
• Nitric Oxide Suppresses Apoptosis via Interrupting Caspase Activation and Mitochondrial Dysfunction in Cultured Hepatocytes*

  1999cited by this paper
• Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma.

  1999cited by this paper
• The Fas counterattack: cancer as a site of immune privilege.

  1999influential reference
• Gamma Interferon Stimulates Rat Alveolar Macrophages To Kill Pneumocystis carinii byl-Arginine- and Tumor Necrosis Factor-Dependent Mechanisms

  1999cited by this paper
• Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.

  1999cited by this paper
• Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

  1999cited by this paper
• Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege

  1999cited by this paper
• Adoptive T-cell immunotherapy of cancer.

  1999cited by this paper
• Human melanoma cells do not express Fas (Apo-1/CD95) ligand.

  1999cited by this paper
• Developing recombinant and synthetic vaccines for the treatment of melanoma.

  1999cited by this paper
• Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy.

  1999cited by this paper
• Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.

  1999cited by this paper
• Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.

  1999cited by this paper
• Gamma Interferon Modulates CD95 (Fas) and CD95 Ligand (Fas-L) Expression and Nitric Oxide-Induced Apoptosis during the Acute Phase ofTrypanosoma cruzi Infection: a Possible Role in Immune Response Control

  1999cited by this paper
• How tumors escape immune destruction and what we can do about it

  1999cited by this paper
• Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.

  1998cited by this paper
• T cell–tumor cell: a fatal interaction?

  1998cited by this paper
• Tumor expression of Fas ligand (CD95L) and the consequences.

  1998cited by this paper
• New opportunities for the development of cancer immunotherapies.

  1998cited by this paper
• Cancer vaccines

  1998cited by this paper
• Immune Suppression by Recombinant Interleukin (rIL)-12 Involves Interferon γ Induction of Nitric Oxide Synthase 2 (iNOS) Activity: Inhibitors of NO Generation Reveal the Extent of rIL-12 Vaccine Adjuvant Effect

  1998cited by this paper
• Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice.

  1998cited by this paper
• Nitric oxide causes apoptosis in pulmonary vascular smooth muscle cells.

  1998cited by this paper
• The role of Fas/FasL in immunosuppression induced by human tumors

  1998cited by this paper
• Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma

  1997cited by this paper
• Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases

  1997cited by this paper
• Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells.

  1997cited by this paper
• Characterization of tumor necrosis factor-deficient mice.

  1997cited by this paper
• Gene Therapy for Metastatic Brain Tumors by Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Tumor Cells

  1997cited by this paper
• Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.

  1997cited by this paper
• Therapy with cultured T cells: principles revisited

  1997cited by this paper
• Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae

  1997cited by this paper
• Escape from host-antitumor immunity.

  1997cited by this paper
• Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.

  1996cited by this paper
• Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β

  1996cited by this paper
• Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitro

  1996cited by this paper
• Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta.

  1996cited by this paper
• The neglected role of type I interferon in the T-cell response: implications for its clinical use.

  1996cited by this paper
• Alterations in T cells of cancer-bearers: whence specificity?

  1996cited by this paper
• Induction of apoptosis in mature T cells by tumour necrosis factor

  1995influential reference
• Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha.

  1994cited by this paper
• A fluorometric assay for the measurement of nitrite in biological samples.

  1993influential reference
• Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.

  1993cited by this paper
• Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C

  1991cited by this paper
• Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state.

  1991cited by this paper
• Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

  1990cited by this paper
• Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages.

  1990cited by this paper
• Differential regulation of gene expression during macrophage activation with a polyribonucleotide. The role of endogenously derived IFN.

  1988cited by this paper
• Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.

  1986cited by this paper
• Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.

  1986cited by this paper

• Oleic acid restores the impaired antitumor immunity of γδ-T cells induced by palmitic acid

  2025cites this paper
• Nitric oxide-modulating biomaterials for therapeutic Immunoengineering.

  2025cites this paper
• Prognostic significance of systemic immune inflammation index and systemic inflammation response index for cervical cancer: A systematic review and meta-analysis

  2025cites this paper
• Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets

  2025cites this paper
• Targeting amino acid-metabolizing enzymes for cancer immunotherapy

  2024cites this paper
• Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity

  2024cites this paper
• Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma

  2024cites this paper
• Immunotherapy-activated T cells recruit and skewlate-stage activated M1-like macrophagesthat are critical for therapeutic efficacy.

  2024cites this paper
• EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer

  2023cites this paper
• Role of neuroinflammation in neurodegeneration development

  2023cites this paper
• Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma

  2023cites this paper
• The prognostic predictive value of systemic immune index and systemic inflammatory response index in nasopharyngeal carcinoma: A systematic review and meta-analysis

  2023cites this paper
• Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy

  2022cites this paper
• Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

  2022cites this paper
• Monocytes and Macrophages in the Cancer Immunity Cycle

  2022cites this paper
• Immune cell responses in pancreatic cancer and their clinical application

  2022cites this paper
• Th1 polarization in the tumor microenvironment upregulates the myeloid-derived suppressor-like function of macrophages.

  2021cites this paper
• Regulation of T Cells in Cancer by Nitric Oxide

  2021cites this paper
• Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination

  2021cites this paper
• Butyrate modulates adipose-derived stem cells isolated from polygenic obese and diabetic mice to drive enhanced immunosuppression.

  2021cites this paper
• Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma

  2021cites this paper
• Arginine-dependent immune responses

  2021cites this paper
• Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk

  2020cites this paper
• 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.

  2020cites this paper
• Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment

  2020cites this paper
• Emerging neo adjuvants for harnessing therapeutic potential of M1 tumor associated macrophages (TAM) against solid tumors: Enusage of plasticity

  2020cites this paper
• Specific Effects of Trabectedin and Lurbinectedin on Human Macrophage Function and Fate—Novel Insights

  2020cites this paper
• Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion

  2020influential citation
• Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors

  2019cites this paper
• TAMing pancreatic cancer: combat with a double edged sword

  2019cites this paper
• Mechanisms of immune evasion in bladder cancer

  2019cites this paper
• Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis

  2019cites this paper
• Immunonutritional consequences of different serine-type protease inhibitors in a C57BL/6 hepatocarcinoma model

  2019cites this paper
• IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide

  2019cites this paper
• Role of Leukocytes During Hematogenous Metastasis

  2019cites this paper
• IL-1α BLOCKADE REDUCES IMMUNE SUPPRESSION IN THE EARLY TUMOR MICRO-ENVIRONMENT

  2018cites this paper
• Ciblage pharmacologique du microenvironnement de l'adénocarcinome canalaire pancréatique

  2018cites this paper
• Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment

  2017cites this paper
• Energy metabolic pathways control the fate and function of myeloid immune cells

  2017cites this paper
• Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity

  2017cites this paper
• Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.

  2017cites this paper
• Myeloid-Derived Suppressor Cells

  2017cites this paper
• IL-6 Improves the Nitric Oxide-Induced Cytotoxic CD8+ T Cell Dysfunction in Human Chagas Disease

  2016cites this paper
• Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery

  2016cites this paper
• The Role of Immune Modulatory MicroRNAs in Tumors

  2016cites this paper
• Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy

  2015cites this paper
• Radiation epigenetically modulates tumor cells and alters activation and function of effector T cells

  2015cites this paper
• Gaseous mediators in resolution of inflammation.

  2015cites this paper
• Myeloid-derived suppressor cells in B cell malignancies

  2015cites this paper
• Development of antibodies against the canine CSF-1R

  2015cites this paper
• Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.

  2014cites this paper
• all-trans-retinoic acid improves immunocompetence in a murine model of lipopolysaccharide-induced immunosuppression.

  2014cites this paper
• Augmenting Anti-Tumor Immunity By Targeting Macrophage Cox-2 In Breast Cancer

  2014cites this paper
• Apoptosis of T Cells through Down-Regulation and ε Induce CD3 Tumor-Educated Tolerogenic Dendritic Cells

  2014cites this paper
• Tumor-Induced Immune Suppression

  2014cites this paper
• Complex role for the immune system in initiation and progression of pancreatic cancer.

  2014cites this paper
• Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice

  2013cites this paper
• Dichloroacetate improves immune dysfunction caused by tumor‐secreted lactic acid and increases antitumor immunoreactivity

  2013cites this paper
• T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma.

  2013cites this paper
• IL‐10 Contributes to the Suppressive Function of Tumour‐Associated Myeloid Cells and Enhances Myeloid Cell Accumulation in Tumours

  2012cites this paper
• Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.

  2012cites this paper
• Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship

  2012cites this paper
• Using Natural Adjuvants to Stimulate Anti-Tumour Immune Responses

  2012cites this paper
• The Construction of a Plasmid for Detecting the Pathway of Arginine Metabolism in Human Macrophages: a Real-Time Assessment of Macrophage Polarity

  2012cites this paper
• Microenvironment and Immunology Monocytic CCR 2 þ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD 8 T-cell In fi ltration into the Tumor Microenvironment

  2012cites this paper
• Glioblastoma Multiforme Stem Cells

  2011cites this paper
• Tumor immune escape mechanisms that operate during metastasis.

  2011cites this paper
• Dual biological effects of the cytokines interleukin-10 and interferon-γ

  2011cites this paper
• Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?

  2011cites this paper
• Gr-1+ CD11b+ Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in Obesity*

  2011cites this paper
• Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine

  2010cites this paper
• Tumor Cell-Released TLR4 Ligands Stimulate Gr-1+CD11b+F4/80+ Cells to Induce Apoptosis of Activated T Cells

  2010cites this paper
• Induce Apoptosis of Activated T Cells Cells to + F 4 / 80 + CD 11 b + Stimulate Gr-1 Tumor Cell-Released TLR 4 Ligands

  2010cites this paper
• Inactivates Antitumor Effector Phase Lymphocytes + Tumor-Infiltrating CD 8 TCR-Mediated Signal Transduction in Tumor-Induced Disruption of Proximal

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Loss of Inducible Nitric Oxide Synthase Expression in the Mouse Renal Cell Carcinoma Cell Line RENCA Is Mediated by MicroRNA miR-146 a

  2010cites this paper
• Tumor-Induced Disruption of Proximal TCR-Mediated Signal Transduction in Tumor-Infiltrating CD8+ Lymphocytes Inactivates Antitumor Effector Phase

  2010cites this paper
• Expression of RCAS1 protein in microglia/macrophages accompanying brain tumours. An immunofluorescence study.

  2009cites this paper
• INDUCTION OF MACROPHAGE ARGINASE I EXPRESSION BY RON AND THE IMPLICATIONS FOR PROMOTING SYNGENEIC TUMOR GROWTH

  2009cites this paper
• Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60).

  2009cites this paper
• Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer

  2009cites this paper
• HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.

  2009cites this paper
• TGF-β modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression

  2009cites this paper
• Spontaneous Autoimmunity Sufficiently Potent to Induce Diabetes Mellitus Is Insufficient to Protect against Insulinoma1

  2009cites this paper
• Effects of dendritic cell vaccine activated with protein components of toxoplasma gondii on tumor specific CD8+ T-cells

  2009cites this paper
• Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.

  2009cites this paper
• Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec.

  2009cites this paper
• The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression.

  2009cites this paper
• Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses

  2009cites this paper
• Tumor-Induced Impairment of TCR Signaling Results in Compromised Functionality of Tumor-Infiltrating Regulatory T Cells1

  2008cites this paper
• Tumor-Educated Tolerogenic Dendritic Cells Induce CD3ε Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways1

  2008influential citation
• IL-23 / IL-17 Proinflammatory Pathway Tumor-Secreted Lactic Acid Promotes

  2008cites this paper
• Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma1

  2008cites this paper
• Skewing the Th cell phenotype toward Th1 alters the maturation of tumor‐infiltrating mononuclear phagocytes

  2008cites this paper
• Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway1

  2008cites this paper
• Peri- and intratumoral T and B lymphocytic infiltration in breast cancer.

  2008cites this paper
• Regulatory T Cells Functionality of Tumor-Infiltrating Signaling Results in Compromised Tumor-Induced Impairment of TCR

  2008cites this paper
• Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics

  2008cites this paper
• Signaling defects in anti‐tumor T cells

  2008cites this paper
• Overcoming immune evasion in T cell therapy of cancer: lessons from animal models.

  2008cites this paper
• Inhibitory B7-family molecules in the tumour microenvironment

  2008cites this paper